Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111951523 | 11195152 | 3 | F | 20150421 | 20160825 | 20150617 | 20160829 | EXP | CA-ROCHE-1566927 | ROCHE | 63.20 | YR | F | Y | 0.00000 | 20160829 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111951523 | 11195152 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | U | B1008 | 125472 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||||
| 111951523 | 11195152 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | U | B1008 | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 111951523 | 11195152 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 111951523 | 11195152 | 4 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 111951523 | 11195152 | 5 | C | TELMISARTAN. | TELMISARTAN | 1 | 0 | ||||||||||||
| 111951523 | 11195152 | 6 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 111951523 | 11195152 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 111951523 | 11195152 | 8 | C | LYRICA | PREGABALIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111951523 | 11195152 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111951523 | 11195152 | HO |
| 111951523 | 11195152 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111951523 | 11195152 | Abdominal pain | |
| 111951523 | 11195152 | Anxiety | |
| 111951523 | 11195152 | Cholelithiasis | |
| 111951523 | 11195152 | Deafness unilateral | |
| 111951523 | 11195152 | Drug ineffective | |
| 111951523 | 11195152 | Ear infection | |
| 111951523 | 11195152 | Headache | |
| 111951523 | 11195152 | Hepatomegaly | |
| 111951523 | 11195152 | Nephrolithiasis | |
| 111951523 | 11195152 | Pain | |
| 111951523 | 11195152 | Pain in extremity | |
| 111951523 | 11195152 | Pancreatic disorder | |
| 111951523 | 11195152 | Peripheral swelling | |
| 111951523 | 11195152 | Rash | |
| 111951523 | 11195152 | Rheumatoid arthritis | |
| 111951523 | 11195152 | Swelling | |
| 111951523 | 11195152 | Viral infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111951523 | 11195152 | 1 | 20150330 | 0 | ||
| 111951523 | 11195152 | 2 | 20150420 | 0 |